Timothy Maness

Chief Financial Officer at Adaptin BIO.

Raised on Adaptin BIO filings

$1.9M

of $4M offered across 2 Form D filings

Form D filings: 2
Teammates: 6
Last filing: Jun 22, 2026

Company

Biotech · Charlotte, NC

Brain-penetrating T cell therapy for glioblastoma

Brain-penetrating T cell therapy for glioblastoma

Investors: 13
Founded: 2022
Still open: $2.1M

Investors: 13
Sector: Biotech
Founded: 2022
HQ: Charlotte, NC

Adaptin BIO filings

Adaptin BIO Form D filings
Filed	Security	Sold of offered	Filing
Jun 22, 2026	Equity	$1.9M/ $4M	Form D/A
Mar 23, 2026	Equity	$1.7M/ $4M	Form D/A

EquityFiled Jun 22, 2026Form D/A
$1.9M/ $4M
EquityFiled Mar 23, 2026Form D/A
$1.7M/ $4M

Works with

Also named on Adaptin BIO filings

Michael J. RobertsPresident and Chief Executive Officer, Form D signerForm D signer Simon PedderExecutive Chairman J. Nick RiehleDirector L. Arthur HewittChief Development Officer Anthony ZookDirector Patrick GallagherDirector